NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Times story ticks off doc

Posted By


A physician in NY wrote to me today about an article in the New York Times, “After a Stroke, Freeing Muscles With Botox.”

The physician wrote because he felt the article didn’t explain the exact indications for the approach described in the story, didn’t discuss the evidence, and didn’t quantify the alleged benefits. He wrote:

I highlight this because I run into this problem all the time and I could see a run on, “doc, I need this.”

He’s right: none of that information is in the story.

But here is what IS in the story: a projection from one true believer-physician that “only about 5 percent of the stroke patients who could benefit from its use ever get it.” The story goes on to disclose that that doc “gets financing from three botulinum toxin producers.”


You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.